Monocyte count combined with GTVnx is an independent prognostic factor in non-metastatic nasopharyngeal carcinoma receiving radiotherapy
Peripheral blood monocyte count combined with GTVnx is an independent predictor for overall survival and progression free-survival in newly diagnosed non-metastatic NPC patients who received radiotherapy. The benefit of patients with GTVnx< 28.5cm<sup>3</sup> could be remarkably attenuated by the high monocyte count.
Authors
- Minzhen Lu (ORCID: https://orcid.org/0000-0002-8420-9746)
- De-Qing Liu
- Jiang-Dong Sui (ORCID: https://orcid.org/0000-0001-5171-1978)
- Honglei Tu (ORCID: https://orcid.org/0000-0003-3313-9335)
- Yipeng Song (ORCID: https://orcid.org/0000-0002-8845-6939)
- Ying Wang (ORCID: https://orcid.org/0000-0001-8020-3622)
- Huan Zhang (ORCID: https://orcid.org/0000-0003-0452-6678)
- Dan Li (ORCID: https://orcid.org/0000-0002-1264-5952)
- Yue Xie (ORCID: https://orcid.org/0000-0001-8446-3640)
- Lina Yang
Institutions
- Chongqing Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-08
- DOI
- https://doi.org/10.3389/fonc.2025.1541212
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Centre Scientifique et Technique du Bâtiment